Literature DB >> 15107479

Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys.

Jamie M Zeitzer1, Christine L Buckmaster, David M Lyons, Emmanuel Mignot.   

Abstract

The hypocretin system is involved in the integration of hypothalamic functions with sleep and wake. Hypocretin-1 release peaks at the end of the active period in both diurnal and nocturnal species. A role for hypocretin-1 in the generation of locomotor activity has been suggested by electrophysiological and neurochemical studies in rodents, dogs and cats. These species, however, do not consolidate wake into a single, daily bout and manipulations of locomotion elicit changes in wakefulness, making it difficult to parse the relative contribution of these two factors. We have examined the relationship between locomotion and hypocretin-1 in a wake-consolidating animal, the squirrel monkey (Saimiri sciureus). Strikingly, we found that restricting locomotion to 17% of usual activity had no significant effect on the normal diurnal rise in cerebrospinal fluid (CSF) hypocretin-1, despite an associated increase in CSF cortisol. Increasing locomotion to greater than baseline activity did not significantly increase CSF hypocretin-1 concentrations, but did appear to have a positive modulatory effect on CSF hypocretin-1. In this wake-consolidating animal, locomotion is not necessary for CSF hypocretin-1 to increase throughout the daytime, but high levels of locomotion are likely to provide a small positive feedback onto the hypocretin system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107479      PMCID: PMC1665142          DOI: 10.1113/jphysiol.2004.061606

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  38 in total

1.  Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

Authors:  P Bourgin; S Huitrón-Résendiz; A D Spier; V Fabre; B Morte; J R Criado; J G Sutcliffe; S J Henriksen; L de Lecea
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems.

Authors:  Y Date; Y Ueta; H Yamashita; H Yamaguchi; S Matsukura; K Kangawa; T Sakurai; M Yanagisawa; M Nakazato
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

4.  Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system.

Authors:  T L Horvath; C Peyron; S Diano; A Ivanov; G Aston-Jones; T S Kilduff; A N van Den Pol
Journal:  J Comp Neurol       Date:  1999-12-13       Impact factor: 3.215

5.  Hypothalamic hypocretin (orexin): robust innervation of the spinal cord.

Authors:  A N van den Pol
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

6.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

7.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

8.  Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats.

Authors:  T Ida; K Nakahara; T Katayama; N Murakami; M Nakazato
Journal:  Brain Res       Date:  1999-03-13       Impact factor: 3.252

9.  The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats.

Authors:  D C Piper; N Upton; M I Smith; A J Hunter
Journal:  Eur J Neurosci       Date:  2000-02       Impact factor: 3.386

10.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

View more
  9 in total

Review 1.  Addiction and arousal: the hypocretin connection.

Authors:  Benjamin Boutrel; Luis de Lecea
Journal:  Physiol Behav       Date:  2007-11-22

2.  Orexin/hypocretin receptor signalling: a functional perspective.

Authors:  C S Leonard; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

3.  Circadian and Homeostatic Regulation of Human Sleep and Cognitive Performance and Its Modulation by PERIOD3.

Authors:  Derk-Jan Dijk; Simon N Archer
Journal:  Sleep Med Clin       Date:  2009-06-09

4.  Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey.

Authors:  Jamie M Zeitzer; Tohru Kodama; Christine L Buckmaster; Yoshiko Honda; David M Lyons; Seiji Nishino; Emmanuel Mignot
Journal:  J Sleep Res       Date:  2011-09-13       Impact factor: 3.981

Review 5.  Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.

Authors:  Raphaëlle Winsky-Sommerer; Benjamin Boutrel; Luis de Lecea
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

6.  Modafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep.

Authors:  Jamie M Zeitzer; Christine L Buckmaster; Hans-Peter Landolt; David M Lyons; Emmanuel Mignot
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

Review 7.  Daily Fluctuation of Orexin Neuron Activity and Wiring: The Challenge of "Chronoconnectivity".

Authors:  Idris A Azeez; Federico Del Gallo; Luigia Cristino; Marina Bentivoglio
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

8.  Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson's Disease.

Authors:  Milos Stanojlovic; Jean Pierre Pallais; Catherine M Kotz
Journal:  Front Neurosci       Date:  2019-07-30       Impact factor: 4.677

9.  Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants.

Authors:  Tohei Yokogawa; Wilfredo Marin; Juliette Faraco; Guillaume Pézeron; Lior Appelbaum; Jian Zhang; Frédéric Rosa; Philippe Mourrain; Emmanuel Mignot
Journal:  PLoS Biol       Date:  2007-10-16       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.